febuxostat alvogen tablet, film coated 120mg
alvogen malta operations (row) ltd malta life sciences park, building 1, level 4 sir temi, zammit buildings, san gwann, malta - febuxostat - film-coated tablet - febuxostat 120 mg - antigout preparations
feburic 80 mg
neopharm ltd, israel - febuxostat - film coated tablets - febuxostat 80 mg - febuxostat - treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).feburic is indicated in adults.
feburic® film coated tablets 80mg
astellas pharma singapore pte. ltd. - febuxostat - tablet, film coated - febuxostat 80.00 mg
febuxostat tillomed 120 mg film-coated tablets
laboratorios tillomed spain, s.l.u. - febuxostat - film-coated tablet - 120 milligram(s) - febuxostat
febuxostat tillomed 80 mg film-coated tablets
laboratorios tillomed spain, s.l.u. - febuxostat - film-coated tablet - 80 milligram(s) - febuxostat
alloril 300
dexcel ltd, israel - allopurinol - tablets - allopurinol 300 mg - allopurinol - allopurinol - management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis and/or nephropathy). management of patients with leukemia, lymphoma, and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.
alloril 100
dexcel ltd, israel - allopurinol - tablets - allopurinol 100 mg - allopurinol - allopurinol - management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis and/or nephropathy). management of patients with leukemia, lymphoma, and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.
allopurinol 100mg tablets
wockhardt uk limited - allopurinol - tablet - allopurinol 100 mg - antigout preparations
allopurinol 300mg tablets
wockhardt uk limited - allopurinol - tablet - allopurinol 300 mg - antigout preparations
alopron 300 mg tablets
remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - allopurinol - tablet - allopurinol 300 mg - antigout preparations